MANAGEMENT OF A PATIENT WITH ANKYLOSING SPONDYLITIS TYPE SPONDYLOARTHRITIS AND LATENT TUBERCULOSIS INFECTION
Open Access
- 29 January 2021
- journal article
- Published by Universitas Airlangga in Current Internal Medicine Research and Practice Surabaya Journal
- Vol. 2 (1), 19-24
- https://doi.org/10.20473/cimrj.v2i1.23887
Abstract
Ankylosing spondylitis (AS) is one of the most common types of spondylarthritis (SpA) and Disease-Modifying Antirheumatic Drug (DMARD) is one of the modalities for treating the disease. An increased risk of latent tuberculosis infection (LTBI) reactivation in rheumatic patients receiving DMARD has been reported. Management of patients with rheumatic diseases who are also infected with LTBI needs to be understood in order not tobecome active TB. We reported a case of a 57-year-old man with AS. Patient was planned to be treated with DMARD so that hepatitis and TB screening performed. It was discovered that this patient had LTBI. The prophylactic therapy for TB was given. DMARD therapy started 1 month after TB prophylactic therapy was given. For monitoring the disease progression,anamnesis, physical, laboratory, and radiology examination performed regularly.Keywords
This publication has 5 references indexed in Scilit:
- Updates on the risk factors for latent tuberculosis reactivation and their managementsEmerging Microbes & Infections, 2016
- Ankylosing SpondylitisPublished by Elsevier BV ,2013
- Mycobacterial Infections in the Era of Modern Biologic AgentsThe American Journal of the Medical Sciences, 2011
- Antirheumatic Drugs and the Risk of TuberculosisClinical Infectious Diseases, 2006
- Physical properties of cometsVistas in Astronomy, 1984